Relevant studies have shown that some natural small molecules such as berberine and ellagaloic acid can stabilize LDLR mRNA levels through the ERK1/2 pathway, thereby improving NAFLD [48,49]. The gene discussed is LDLR; the disease is metabolic dysfunction-associated steatotic liver disease.